|
Mar 18
|
25 Most Stressed Cities in the United States
|
|
Mar 15
|
Why Is Sage Therapeutics, Inc. (SAGE) Down 22% Since Last Earnings Report?
|
|
Feb 8
|
Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline
|
|
Feb 7
|
Will Sage Therapeutics, Inc. (SAGE) Report Negative Earnings Next Week? What You Should Know
|
|
Jan 8
|
Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Jan 8
|
Sage Therapeutics Announces Changes to Board of Directors
|
|
Jan 2
|
Sage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024
|
|
Dec 20
|
11 Most Promising Psychedelic Stocks According to Hedge Funds
|
|
Dec 7
|
Why Is Sage Therapeutics, Inc. (SAGE) Up 12.7% Since Last Earnings Report?
|
|
Dec 2
|
Strong week for Sage Therapeutics (NASDAQ:SAGE) shareholders doesn't alleviate pain of five-year loss
|
|
Nov 8
|
Sage Therapeutics (SAGE) Q3 Earnings Lag Estimates, Down 5%
|
|
Nov 8
|
Biogen’s Earnings Top Estimates. Wall Street Still Has Questions About Growth.
|
|
Nov 8
|
Sage Therapeutics to Present at Upcoming November Investor Conferences
|
|
Nov 7
|
Why Sage Therapeutics Stock Sank Today
|
|
Nov 7
|
UPDATE 1-Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
|
|
Nov 7
|
Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
|
|
Nov 7
|
Sage Therapeutics, Inc. (SAGE) Reports Q3 Loss, Misses Revenue Estimates
|
|
Nov 7
|
Sage Therapeutics Inc (SAGE) Announces Q3 2023 Financial Results and Highlights Pipeline Progress
|
|
Nov 7
|
Biogen, Sage set price of postpartum depression pill at $15,900
|
|
Nov 7
|
Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
|